Management of the active severe eye changes of Graves' disease.
D000328:Adult; D001327:Autoimmune Diseases / Q000628:therapy; D005260:Female; D006111:Graves Disease / Q000188:drug therapy / Q000209:etiology / Q000601:surgery / Q000628:therapy*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007456:Iodine Isotopes / Q000627:therapeutic use; D008135:Long-Acting Thyroid Stimulator / Q000097:blood; D008297:Male; D008875:Middle Aged; D010900:Pituitary Diseases / Q000150:complications; D011241:Prednisone / Q000627:therapeutic use; D013965:Thyroidectomy
D007166:Immunosuppressive Agents; D007456:Iodine Isotopes; D008135:Long-Acting Thyroid Stimulator; D011241:Prednisone